Nebivolol (Amerigen Pharmaceuticals Inc.)


Welcome to the PulseAid listing for the Nebivolol drug offered from Amerigen Pharmaceuticals Inc.. This Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Amerigen Pharmaceuticals Inc.
NON-PROPRIETARY NAME: Nebivolol
SUBSTANCE NAME: NEBIVOLOL HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2015-04-28
END MARKETING DATE: 0000-00-00


Nebivolol HUMAN PRESCRIPTION DRUG Details:

Item DescriptionNebivolol from Amerigen Pharmaceuticals Inc.
LABELER NAME: Amerigen Pharmaceuticals Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 2.5(mg/1)
START MARKETING DATE: 2015-04-28
END MARKETING DATE: 0000-00-00
PRODUCT ID: 43975-248_02a8038f-f4bf-4f60-9888-b1233fa947d2
PRODUCT NDC: 43975-248
APPLICATION NUMBER: ANDA203659

Other NEBIVOLOL HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Allergan USA, Inc.Bystolic
Amerigen Pharmaceuticals Inc.Nebivolol
Avera McKennan HospitalBystolic
Cardinal HealthBystolic
Carilion Materials ManagementBystolic
Physicians Total Care, Inc.Bystolic